FY25 consensus $34.48. Given the ongoing and industry-wide impact of elevated cost trends in ACA and Medicaid, Elevance Health (ELV) now expects 2025 GAAP net income per diluted share to be approximately $24.10 and adjusted net income per diluted share to be approximately $30.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Notable companies reporting before tomorrow’s open
- Elevance Health price target lowered to $440 from $500 at Truist
- Elevance Health price target lowered to $400 from $478 at Wells Fargo
- Compelling Valuation and Positive Outlook for Elevance Health Despite Margin Uncertainties
- ELV Upcoming Earnings Report: What to Expect?